PTEN and metastatic malignant neoplasm in the lymph nodes: No statistically significant correlations between the loss of cytoplasmic, nuclear or total PTEN expression with other clinicopathological characteristics, including gender, age, depth of invasion, lymph node metastasis and distant metastasis were observed (Table I).